Busulfan levels are influenced by prior treatment and are associated with hepatic veno-occlusive disease and early mortality but not with delayed complications following marrow transplantation - Copelan,E.A.; Bechtel,T.P.; Avalos,B.R. (Bone Marrow Transplant, 2001)